Study on effectiveness of bevacizumab for treatment of radiation necrosis in the brain caused by gamma knife radiation therapy
Not Applicable
- Conditions
- Radiation necrosis in the brain
- Registration Number
- JPRN-UMIN000034959
- Lead Sponsor
- Department of Neurology, Aizawa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
Association of contraindication of bevacizumab
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of symptoms and MRI findings 2 years after initial treatment with bevacizumab.
- Secondary Outcome Measures
Name Time Method 1)Safety 2)re-exacerbation with 2 years after initial treatment with bevacizumab.